DMD and Becker muscular dystrophy: These trials have demonstrated that direct intramuscular injection or systemic delivery of two different oligomers, to DMD patients with amenable mutations, could excise dystrophin exon 51, thereby restoring the reading-frame and result in expression of correctly localised Becker muscular dystrophy (BMD)-like dystrophin isoforms.